Table 3 Correlations the clinical characteristics among CCL19 and non-cirrhotic HCC in TCGA
Variables | N | Non-cirrhotic HCC | |
|---|---|---|---|
CCL19 | |||
Low/high expression case (n) | p value | ||
Gender | |||
 Male | 82 | 64/18 | 0.585 |
 Female | 50 | 41/9 | |
Age at diagnosis | |||
 ≥ 60 | 80 | 68/12 | 0.054 |
 < 60 | 52 | 37/15 | |
T stage | |||
 T1/T2 | 97 | 76/21 | 0.846 |
 T3/T4 | 33 | 27/6 | |
 TX | 1 | 1/0 | |
 NA | 1 | 1/0 |  |
N stage | |||
 N0 | 91 | 73/18 | 0.853 |
 N1 | 1 | 1/0 | |
 NX | 40 | 31/9 | |
M stage | |||
 M0 | 90 | 74/16 | 0.178 |
 M1 | 4 | 2/2 | |
 MX | 38 | 29/9 | |
Pathologic stage | |||
 I/II | 91 | 72/19 | 0.741 |
 III/IV | 33 | 27/6 | |
 NA | 8 | 6/2 | |
Vascular invasion | |||
 None | 87 | 69/18 | 1.000 |
 Micro | 33 | 26/7 | |
 Macro | 6 | 5/1 | |
 NA | 6 | 5/1 | |
HBV infection | |||
 Yes | 38 | 27/11 | 0.176 |
 No | 88 | 72/16 | |
 NA | 6 | 6/0 | |
HCV infection | |||
 Yes | 14 | 7/7 | 0.016 |
 No | 112 | 92/20 | |
 NA | 6 | 6/0 | |